Market Research Future (MRFR) latest study finds that the
global catheter stabilization market is set to surge at 7.1% CAGR from 2022 to
2030. Catheter stabilization devices are standard class for suture-free
stabilization of peritoneal lavage and nephrostomy and biliary percutaneous
drainage catheters.
These devices play
an important during procedures that involve the use of catheters.
Cardiac, neurology, urological are among the major areas where catheter
stabilization finds application. The rising incidence of cardiac incidence is
one of the major factors driving the market growth. In 2015, cardiovascular
diseases accounted for more than 17 Mn deaths. Of these, over 6 Mn deaths were
due to stroke and more than 7 Mn were due to coronary heart diseases. The data
released by the American Heart Association cardiovascular diseases accounted
for nearly 801,000 deaths in 2017. The healthcare cost of cardiovascular
treatment is anticipated to reach USD 1044 Bn by the year 2020.
Segmental Overview
MRFR’s study includes
a detailed segmental analysis of the global catheter stabilization market based on
application, product type, end user and region.
By application, the
market has been segmented into respiratory procedures, general surgery,
radiology, cardiovascular procedures, urological procedures, gastric and
oropharyngeal procedures and others. By product type, the market has been
segmented into arterial securement devices, central venous catheter securement
devices, peripheral securement devices, chest drainage tube securement devices,
abdominal drainage tubes securement devices, epidural securement devices. The
central venous catheter securement devices segment covers jugular securement
devices, PICC securement devices, midlines securement devices, portal
securement devices, subclavian securement devices and femoral securement
devices. The peripheral securement devices segment covers nasogastric tubes
securement devices, continuous nerve block catheter securement devices, chest
drainage tube securement devices, foley catheter securement devices,
endotracheal tube securement devices, ventriculoperitoneal securement devices.
Abdominal drainage tube securement devices segment covers umbilical catheter
securement devices, jejunal catheter securement devices and percutaneous
endoscopic gastrostomy securement devices. By end users, the market has been
segmented into diagnostic centers, home healthcare providers and hospitals
& clinics.
Competitive
Analysis
Some of top-notch
companies operating in the global catheter stabilization market include B.
Braun Melsungen Ag, C. R. Bard, Inc. Convatec, Inc., Medtronic PLC, M.C.
Johnson Company, Inc., 3M Company, TIDI Products, LLC., Baxter International,
Inc., Merit Medical Systems, Inc., Centurion Medical Products, and Smiths Group
PLC.
Global Catheter
stabilization market: Regional Segmentation
On the basis of
region, the market has been segmented into Asia Pacific, Europe, Americas and
the Middles East & Africa (MEA). The market catheter stabilization market
in Americas is expected to remain highly attractive during the forecast period.
Presence of advanced healthcare infrastructure and faster adoption of
innovative healthcare technologies are some of factors supporting the market
growth in Americas, especially North America.
In terms of
revenue, Europe holds the second spot. Increased prevalence of chronic diseases
and cardiovascular disorders in the region is driving the demand for
catheter-based procedures. Moreover, high healthcare expenditure and presence
of public healthcare policies continues to favour the market in Europe.
Asia Pacific is
also viewed as a crucial market for catheter stabilization device. In fact, the APAC
catheter stabilization market is projected to witness a relatively faster
growth during the forecast period. Growing need for effective diagnostic
services and increased focus of improving healthcare infrastructure and an
ever-growing patient pools are factors that make APAC a market with significant
potentials.
Industry News
- American healthcare technology company Abbott
Laboratories has reportedly received the green signal from FDA for its
novel sensor enabled TactiCath Contract Force Ablation Catheter. The
catheter has been there in the Europe market for couple of years now.
- Penumbra, a healthcare company that develops
suction-based stroke clot removal devices has recently introduce two new
devices; Penumbra JET 7 and Penumbra JET D Reperfusion Catheters.
About
Market Research Future:
At
Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have
supreme objective to provide the optimum quality market research and intelligence
services to our clients.
Contact
us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99
Hudson Street, 5Th Floor,
New
York, New York 10013
United
States of America
+1 628
258 0071
Email:
sales@marketresearchfuture.com
Comments
Post a Comment